Researchers from the University of Pittsburg Medical Center have found specific genetic mutations that revealed which pancreatic cancer tumors could be susceptible to existing chemotherapy drugs, according to an analysis published in Gastroenterology.
Nathan Bahary, MD, PhD, an oncologist at UPMC Hillman Cancer Center, in Pittsburgh, said in a press release that their findings could help match patients to treatments.
“People have been looking for such markers for a long time, and our study shows that it’s possible to break pancreatic cancer patients into different treatment buckets,”

Source link